Overview Fundamentals API Earnings EOD API Sample Code Pricing

23Andme Holding Co (ME NASDAQ) stock market data APIs

$0.5371 0.05(10.3%) as of July 15, 2024
Price chart is built with Anychart

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the development of novel therapies; and research and development of programs in various therapeutic areas, such as oncology, immunological and inflammatory diseases, and other disease areas, as well as engages in the out-licensing of intellectual property associated with identified drug targets and expenses related to the discovery and development of therapeutic product candidates. This segment also comprises a therapeutics product portfolio, including 23ME-00610 (P006), a humanized monoclonal antibody that interfere with the ability of CD200R1 to interact with CD200 in cancer cells; GSK6097608, an immuno-oncology program for targeting CD96; and 23ME-01473 is an immuno-oncology antibody program that targets the ULBP6 proteins in the NKG2D pathway. 23andMe Holding Co. was founded in 2006 and is headquartered in South San Francisco, California.

23Andme Holding Co Financial Data Overview

0.4858
0.5371
-
0.5403
0.4721
0.35-2.03
237 M
324 M
220 M
-0.11
1.214
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ME',
Type: 'Common Stock',
Name: '23Andme Holding Co',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00XV5CYH5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1804591',
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: '2020-11-23',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: NULL,
IsDelisted: false,
}

23Andme Holding Co Fundamental Data is available in our Financial Data APIs

  • Net Revenue 220 M
  • EBITDA -265 328 992
  • Earnings Per Share -1.4
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get 23Andme Holding Co Earnings via APIs

  • Latest Release 2024-05-23
  • EPS/Forecast -0.15

Get 23Andme Holding Co End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com